Pediatr Surg Int DOI 10.1007/s00383-015-3730-z
ORIGINAL ARTICLE
Familial hirschsprung’s disease: a systematic review Danielle Mc Laughlin1 • Prem Puri1
Accepted: 23 June 2015 Ó Springer-Verlag Berlin Heidelberg 2015
Abstract Introduction Hirschsprung’s disease (HSCR) is a multigenetic disorder with complex inheritance patterns. Population risk is 1 in 5000 but is reported to be increased in families of patients with HSCR. Appropriate counseling of affected families could be assisted by data from a large volume of patients. It was the aim of this study to systematically analyse the patterns of familial HSCR in the published literature. Methods Pubmed Ò database was searched using the terms ‘‘Hirschsprung’s disease’’ and ‘‘familial’’ for studies published between 1980 and 2015 on cohorts of index patients with HSCR reporting on familial recurrence. Studies giving rates of familial HSCR together with the total number of HSCR cases at that centre were included. Results In 4331 index cases of HSCR, an overall rate of 7.6 % familial recurrence was found. In total colonic aganglionosis, 20 % of cases were familial. Recurrence of HSCR within families predominantly occurred in siblings (62 %) and was reported between parent and offspring in 22 % and in other relatives in 16 %. Multiple generations were affected in 15 % of families. Conclusion Familial recurrence of HSCR occurs frequently and should be discussed with families of diagnosed patients. Genetic counseling should be offered in these families and in particular for those patients with long segment and total colonic aganglionosis.
& Prem Puri [email protected] 1
National Children’s Research Centre, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, Ireland
Keywords Hirschsprung’s Disease Familial Total colonic aganglionosis
Introduction Hirschsprung’s disease (HSCR) is a congenital disorder of bowel motility which arises in approximately 1 in 5000 newborns per annum. It is characterised by the absence of ganglion cells in the enteric nervous system extending for a variable distance from the internal anal spincther, due to failure of neural crest derived precursor cell migration or survival during early development [1]. The resulting loss of colonic motility leads to bowel obstruction necessitating corrective surgery to resect the affected segment of colon with pullthrough of normally ganglionated bowel to the anal margin [2]. The functional outcome after surgery for affected children can be influenced by the extent of aganglionosis as well as the presence of co-morbidities [3]. Poor outcomes particularly occur in patients with total colonic aganglionosis (TCA), which accounts for 9 % of all HSCR cases [4]. Disease burden on families can be heightened by the recurrence of HSCR in multiple siblings as well as the inheritance of HSCR in offspring of affected patients. Counseling requires the availability of accurate information for families. HSCR is a multi-genetic condition with complex aetiology [5]. Mutations in RET proto-oncogene and endothelin receptor B (ENDRB) are the most frequent genetic insults [6]. HSCR usually occurs in isolation but can arise in association with Trisomy 21 (up to 10 % of all HSCR) and many other syndromes [7]. Familial recurrence of syndromic forms of HSCR has been reported, for example in multiple endocrine neoplasia (MEN) 2A resulting from RET mutation and in Shah-Waardenburg (WS4) syndrome due to ENDRB mutation [8, 9]. However,
123
Pediatr Surg Int
the majority of HSCR cases are sporadic and are lack definite genetic cause ([80 %). Families of patients with sporadic HSCR are also reported to have an increased risk of HSCR compared to the population risk. In some of these families, genetic screening can identify genetic susceptibility for the disease [10]. Single centre cohort studies report familial recurrence rates for sporadic HSCR ranging from 1 to 10 % [11, 12], illustrating a need for large volume patient data analysis. It was the purpose to this study to review the existing literature in a systematic fashion to identify the rate and patterns of familial recurrence of HSCR.
Methods The Pubmed Ò database was searched using the terms ‘‘Hirschsprung’s’’ and ‘‘familial’’ for studies published between 1980 and 2015. Articles yielded using this search were identified as relevant by abstract review followed by full text analysis. Additional studies of interest were identified by examination of reference lists in relevant articles. Studies including a minimum cohort of 10 index patients with sporadic HSCR were included for the main analysis. Only studies that gave the total number of sporadic HSCR at that centre and reported on familial recurrence were permitted. Studies of multicentre survey data were excluded to avoid duplicated patient cohorts in the analysis. The rate of familial HSCR was calculated as a percentage of the overall number of HSCR cases included in the analysis. Cohorts of patients with TCA were analysed separately. Familial HSCR occurring in association with syndromes or specific genetic mutations was excluded from the main analysis and reported on separately and permitted data from case reports. Patterns of familial HSCR were extracted and categorized as parent–child, sibling or other relative and were reported as a percentage of the total number of families for which recurrence patterns were available. The gender as well as extent of aganglionic segment (long or short) in familial cases were also recorded.
Table 1 Familial recurrence in Hirschsprung’s Disease References
HSCR cases n
Familial cases n
Badner et al. [19]
218
8
Bjornland et al. [20]
48
4
Carter et al. [18]
207
21 3
Cilley et al. [21]
15
De Lagauise et al [22]
55
2
Engum et al. [12]
260
20
Fitze et al. [23]
76
5
Fortuna et al. [24]
82
6
Jakobson-Setton et al. [25]
21
3
Jung et al. [26]
137
4
Klein et al. [27] Koh et al. [28]
26 14
3 2
Lee et al. [29]
44
0
Levitt et al. [11]
67
2
Luis et al. [30]
100
12
Marty et al. [31]
135
23
Moore et al. [32]
118
18
Moore et al. [33]
370
28
More et al. [34]
54
2
Mir et al. [35]
10
1
Murthi et al. [36]
63
2
Neuvonen et al. [37]
146
15
Orr et al. [38]
103
5
Pini Prato et al. [39]
112
9
Reding et al. [40]
59
4
Ruiz-Ferrer et al. [41]
217
27
Russell et al. [42] Ryan et al. [43]
224 179
11 13
Sarioglu et al. [44]
302
6
Shinall et al. [45]
60
2 3
Nah et al. [46]
76
Shono et al. [47]
110
14
Svensson et al. [48]
69
7
Virtanen et al. [49]
91
15
Wang et al. [50]
147
5
Weber et al. [51]
107
8
Yanchar et al. [52]
107
14
Ziad et al. [53]
102
3
Total
4331
330
Results The database search yielded 244 articles. Following abstract review and full text analysis, 38 studies were identified for inclusion in the main analysis (Table 1). In 4331 index cases of HSCR, there were 330 cases in which a family history of HSCR was recorded, giving an overall rate of 7.6 % for familial recurrence. In children with total
123
colonic aganglionosis (n = 525), 20 % of cases were reported to have familial recurrence (Table 2). Recurrence of HSCR within families predominantly occurred in siblings (62 %) and was reported between parent and child in 22 % and in other relatives in 16 %. Multiple generations ([2) were affected in 15 % of families. The gender of familial cases was reported in 202 cases and exhibited a
Pediatr Surg Int Table 2 Familial recurrence in total colonic aganglionois References
TCA cases n
Familial n
Anupuma et al. [54]
25
0
Azzis et al. [55]
16
2
Barrena et al. [56]
41
12
Bickler et al. [57]
21
7
Cass et al. [58]
32
5
Choe et al. [59]
17
4
Dykes et al. [60]
9
1
Emslie et al. [61]
5
1
Escobar et al. [62]
36
10
Festen et al. [63]
11
4
Galifer et al. [64] Hernadez et al. [65]
6 15
1 3
Hoehner et al. [66]
29
4
Marty et al. [31]
12
6
Menezes et al. [67]
58
5
Moore et al. [32]
22
7
Moore et al. [33]
30
11
N-fekete et al. [68]
27
5
Raboei et al. [69]
12
4
Shen et al. [70]
29
4
Travassos et al. [71]
15
2
Tsuji et al. [72]
48
10
Yeh et al. [73]
9
2
Total
525
110
Table 3 Familial recurrence in syndromic HSCR Syndrome
Gene
No. families
RET mutation
RET
42
MEN
RET/GFRA1
19
WS4
ENBRB
14
Goldberg Shprintzen
KIAA1279
7
Neurblastoma
PHOX2B
3
Bardet biedl
–
3
Congenital central hypoventilation
PHOX2B
2
Mowat wilson
ZFH1B
1
Smith lemli optiz
DHCR7
0
ratio of 1.65:1 male:female. Disease segment length was available in 141 cases of familial HSCR only. 39 % of cases were classified as long segment (defined in most studies as proximal to the midpoint of the transverse colon), and 61 % of cases were classified as short segment disease. Recurrence of syndromic HSCR in families was infrequent and is summarised in Table 3. RET mutation or
MEN2A association were the most widely reported [13, 14]. An extended family of Mennonite kindred in the US with a 1 in 500 incidence of HSCR with a susceptibility locus mutation in ENDRB and features of Waardenburg syndrome also featured prominently in the literature [8].
Discussion Our analysis suggests that familial recurrence of HSCR occurs at a higher rate than previously reported by multicentre survey data from the EU (2.6 %) [15] and Japan [16] (2.8–6 %), but our results are similar to a US study which included survey data [17]. We observed high variability in rates of familial recurrence between different centres (Table 3). Nonetheless, this analysis most likely underestimates the rate of familial recurrence of HSCR. In general, the studies included have not been specifically designed to report comprehensive familial data. Recurrence in potential future siblings or other relatives of index patients was not captured. In addition, recurrence in offspring of affected patients is not addressed in any of these studies by longterm follow-up with some exceptions [18]. A relative risk of recurrence of 4 % (200 times the population risk) in siblings has previous been suggested using predictive models [19]; however, further data are required to predict recurrence risk for the future offspring of index patients. These findings reinforce the need for comprehensive follow-up of these and other patients with congenital disorders on a long-term basis to enhance understanding of disease mechanisms for aetiological and clinical purposes. We found that HSCR recurred at a higher rate in families of patients with TCA (in 1 of every 5 cases). These findings are consistent with reports suggesting that TCA represents a distinct entity in terms of aetiology, displaying increased penetrance and dominant inheritance in families of affected patients rather than the multifactorial or recessive patterns of inheritance in other HSCR [6]. Cases of familial recurrence of syndromic HSCR are predominantly limited to RET mutation together with MEN2A or ENDRB mutation together with Shah-Wardenburg syndrome. Other syndromic associations recur within families only very rarely according to the case report literature. Models analysing the gender and the length of the aganglionic segment in index patients have been reported to predict risk of recurrence of HSCR in siblings [19]. We noted that the proportion of female familial cases differed from sporadic HSCR which normally has a male preponderance of 4:1. We additionally noted that a higher number of long segment cases were reported in the familial cases (40 %) than would be expected for sporadic HSCR (15 %).
123
Pediatr Surg Int
In conclusion, familial recurrence of HSCR is frequent and should be discussed with families of index patients. Genetic counseling should be offered in these families and in particular for those patients with long segment and total colonic aganglionosis.
References 1. Heanue TA, Pachnis V (2007) Enteric nervous system development and Hirschsprung’s disease: advances in genetic and stem cell studies. Nat Rev Neurosci 8(6):466–479. doi:10.1038/ nrn2137 2. Langer JC (2012) Laparoscopic and transanal pull-through for Hirschsprung disease. Semin Pediatr Surg 21(4):283–290. doi:10. 1053/j.sempedsurg.2012.07.002 3. Menezes M, Corbally M, Puri P (2006) Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int 22(12):987–990. doi:10.1007/ s00383-006-1783-8 4. Laughlin DM, Friedmacher F, Puri P (2012) Total colonic aganglionosis: a systematic review and meta-analysis of longterm clinical outcome. Pediatr Surg Int 28(8):773–779. doi:10. 1007/s00383-012-3117-3 5. Alves MM, Sribudiani Y, Brouwer RW, Amiel J, Antinolo G, Borrego S, Ceccherini I, Chakravarti A, Fernandez RM, GarciaBarcelo MM, Griseri P, Lyonnet S, Tam PK, van Ijcken WF, Eggen BJ, te Meerman GJ, Hofstra RM (2013) Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model. Dev Biol 382(1):320–329. doi:10. 1016/j.ydbio.2013.05.019 6. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, Pelet A, Arnold S, Miao X, Griseri P, Brooks AS, Antinolo G, de Pontual L, Clement-Ziza M, Munnich A, Kashuk C, West K, Wong KK, Lyonnet S, Chakravarti A, Tam PK, Ceccherini I, Hofstra RM, Fernandez R, Hirschsprung Disease C (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45(1):1–14. doi:10.1136/jmg. 2007.053959 7. Moore SW (2012) Chromosomal and related mendelian syndromes associated with hirschsprung’s disease. Pediatr Surg Int 28(11):1045–1058 8. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell 79(7):1257–1266 9. Verdy M, Weber AM, Roy CC, Morin CL, Cadotte M, Brochu P (1982) Hirschsprung’s disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr 1(4):603–607 10. Garcia-Barcelo M, Sham MH, Lee WS, Lui VC, Chen BL, Wong KK, Wong JS, Tam PK (2004) Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease. Clin Chem 50(1):93–100. doi:10.1373/ clinchem.2003.022061 11. Levitt MA, Hamrick MC, Eradi B, Bischoff A, Hall J, Pena A (2013) Transanal, full-thickness, Swenson-like approach for Hirschsprung disease. J Pediatr Surg 48(11):2289–2295. doi:10. 1016/j.jpedsurg.2013.03.002 12. Engum SA, Petrites M, Rescorla FJ, Grosfeld JL, Morrison AM, Engles D (1993) Familial Hirschsprung’s disease: 20 cases in 12 kindreds. J Pediatr Surg 28(10):1286–1290
123
13. Decker RA, Peacock ML (1998) Occurrence of MEN 2a in familial Hirschsprung’s disease: a new indication for genetic testing of the RET proto-oncogene. J Pediatr Surg 33(2):207–214 14. Coyle D, Friedmacher F, Puri P (2014) The association between Hirschsprung’s disease and multiple endocrine neoplasia type 2a: a systematic review. Pediatr Surg Int 30(8):751–756. doi:10. 1007/s00383-014-3538-2 15. Bourdelat D, Vrsansky P, Pages R, Duhamel B (1997) Duhamel operation 40 years after: a multicentric study. Eur J pediatr surg 7(2):70–76. doi:10.1055/s-2008-1071057 16. Vrsansky P, Bourdelat D, Pages R (1998) Principal modifications of the Duhamel procedure in the treatment of Hirschsprung’s disease. Analysis based on results of an international retrospective study of 2,430 patients. Pediatr Surg Int 13(2–3):125–132 17. Kleinhaus S, Boley SJ, Sheran M, Sieber WK (1979) Hirschsprung’s disease—a survey of the members of the surgical section of the American Academy of Pediatrics. J Pediatr Surg 14(5):588–597 18. Carter CO, Evans K, Hickman V (1981) Children of those treated surgically for Hirschsprung’s disease. J Med Genet 18(2):87–90 19. Badner JA, Sieber WK, Garver KL, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Hum Genet 46(3):568–580 20. Bjornland K, Diseth TH, Emblem R (1998) Long-term functional, manometric, and endosonographic evaluation of patients operated upon with the Duhamel technique. Pediatr Surg Int 13(1):24–28 21. Cilley RE, Statter MB, Hirschl RB, Coran AG (1994) Definitive treatment of Hirschsprung’s disease in the newborn with a onestage procedure. Surgery 115(5):551–556 22. De Lagausie P, Carricaburu E, Ferkadji L, Huaut O, Aigrain Y (2004) Laparoscopic Duhamel procedure: management of 55 cases. Pediatr Endosurg Innov Tech 8(2):119–122. doi:10.1089/ 1092641041360913 23. Fitze G, Appelt H, Ko¨nig IR, Go¨rgens H, Stein U, Walther W, Gossen M, Schreiber M, Ziegler A, Roesner D, Schackert HK (2003) Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Hum Mol Genet 12(24):3207–3214 24. Fortuna RS, Weber TR, Tracy TF Jr, Silen ML, Cradock TV (1996) Critical analysis of the operative treatment of Hirschsprung’s disease. Arch Surg 131(5):520–524 25. Jakobson-Setton A, Weissmann-Brenner A, Achiron R, Kuint J, Gindes L (2015) Retrospective analysis of prenatal ultrasound of children with Hirschsprung disease. Prenat Diagn 35(7):699–702. doi:10.1002/pd.4595 26. Jung PM (1995) Hirschsprung’s disease: one surgeon’s experience in one institution. J Pediatr Surg 30(5):646–651 27. Klein MD, Coran AG, Wesley JR, Drongowski RA (1984) Hirschsprung’s disease in the newborn. J Pediatr Surg 19(4):370–374 28. Koh CE, Yong TL, Fenton EJ (2008) Hirschsprung’s disease: a regional experience. ANZ J Surg 78(11):1023–1027. doi:10. 1111/j.1445-2197.2008.04724.x 29. Lee CC, Lien R, Chiang MC, Yang PH, Chu SM, Fu JH, Lai JY (2012) Clinical impacts of delayed diagnosis of Hirschsprung’s disease in newborn infants. Pediatr Neonatol 53(2):133–137. doi:10.1016/j.pedneo.2012.01.011 30. Luis LA, Encinas JL, Avila LF, Andre´s AM, Burgos L, Ferna´ndez A, Queiza´n A, Olivares P, Lo´pez-Santamarı´a M, Burgos E, Herna´ndez F, Lassaletta L, Tovar JA (2006) Hirschsprung disease: lessons learned from the last 100 cases. Cir Pediatr 19(3):177–181 31. Marty TL, Seo T, Matlak ME, Sullivan JJ, Black RE, Johnson DG (1995) Gastrointestinal function after surgical correction of
Pediatr Surg Int
32.
33.
34.
35.
36.
37.
38. 39.
40.
41.
42. 43.
44.
45.
46.
47.
48.
49.
Hirschsprung’s disease: long-term follow-up in 135 patients. J Pediatr Surg 30(5):655–658 Moore SW, Zaahl M (2010) Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 ‘‘Janus’’ genetic variation. J Pediatr Surg 45(2):393–396. doi:10.1016/j.jpedsurg.2009.10.080 Moore SW, Rode H, Millar AJ, Albertyn R, Cywes S (1991) Familial aspects of Hirschsprung’s disease. Eur J Pediatr Surg 1(2):97–101 More K, Rao S, McMichael J, Minutillo C (2014) Growth and developmental outcomes of infants with Hirschsprung disease presenting in the neonatal period: a retrospective study. J Pediatr 165(1):73–77. doi:10.1016/j.jpeds.2014.02.062 Mir E, Karaca I, Gu¨nsar C, Sencan A, Fesc¸ekoglu O (2001) Primary Duhamel-Martin operations in neonates and infants. Pediatr Int 43(4):405–408 Murthi GV, Raine PA (2003) Preoperative enterocolitis is associated with poorer long-term bowel function after Soave-Boley endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg 38(1):69–72 Neuvonen MI, Kyrklund K, Lindahl HG, Koivusalo AI, Rintala RJ, Pakarinen MP (2015) A population-based, complete followup of 146 consecutive patients after transanal mucosectomy for Hirschsprung disease. J Pediatr Surg. doi:10.1016/j.jpedsurg. 2015.02.006 Orr JD, Scobie WG (1983) Presentation and incidence of Hirschsprung’s disease. Br Med J (Clin Res Ed) 287(6406):1671 Pini Prato A, Gentilino V, Giunta C, Avanzini S, Parodi S, Mattioli G, Martucciello G, Jasonni V (2008) Hirschsprung’s disease: 13 years’ experience in 112 patients from a single institution. Pediatr Surg Int 24(2):175–182 Reding R, de Ville de Goyet J, Gosseye S, Clapuyt P, Sokal E, Buts JP, Gibbs P, Otte JB (1997) Hirschsprung’s disease: a 20-year experience. J Pediatr Surg 32(8):1221–1225 Ruiz-Ferrer M, Torroglosa A, Luzo´n-Toro B, Ferna´ndez RM, Antin˜olo G, Mulligan LM, Borrego S (2011) Novel mutations at RET ligand genes preventing receptor activation are associated to Hirschsprung’s disease. J Mol Med. 89(5):471–480. doi:10.1007/ s00109-010-0714-2 Russell MB, Russell CA, Fenger K, Niebuhr E (1994) Familial occurrence of Hirschsprung’s disease. Clin Genet 45(5):231–235 Ryan ET, Ecker JL, Christakis NA, Folkman J (1992) Hirschsprung’s disease: associated abnormalities and demography. J Pediatr Surg 27(1):76–81 Sarioglu A, Tanyel FC, Bu¨yu¨kpamukc¸u N, Hic¸so¨nmez A (1997) Hirschsprung-associated congenital anomalies. Eur J Pediatr Surg 7(6):331–337 Shinall MC Jr, Koehler E, Shyr Y, Lovvorn HN 3rd (2008) Comparing cost and complications of primary and staged surgical repair of neonatally diagnosed Hirschsprung’s disease. J Pediatr Surg 43(12):2220–2225. doi:10.1016/j.jpedsurg.2008.08.048 Nah SA, de Coppi P, Kiely EM, Curry JI, Drake DP, Cross K, Spitz L, Eaton S, Pierro A (2012) Duhamel pull-through for Hirschsprung disease: a comparison of open and laparoscopic techniques. J Pediatr Surg 47(2):308–312. doi:10.1016/j.jpedsurg. 2011.11.025 Shono K, Hutson JM (1994) The treatment and postoperative complications of Hirschsprung’s disease. Pediatr Surg Int 9(5–6):362–365 Svensson PJ, Molander ML, Eng C, Anvret M, Nordenskjo¨ld A (1998) Low frequency of RET mutations in Hirschsprung disease in Sweden. Clin Genet 54(1):39–44 Virtanen VB, Pukkala E, Kivisaari R, Salo PP, Koivusalo A, Arola J, Miettinen PJ, Rintala RJ, Perola M, Pakarinen MP (2013)
50.
51.
52.
53.
54.
55.
56.
57.
58. 59.
60. 61.
62.
63.
64.
65.
66.
67.
68.
Thyroid cancer and co-occurring RET mutations in Hirschsprung disease. Endocr Relat Cancer 20(4):595–602. doi:10.1530/ERC13-0082 Wang JS, Lee HC, Huang FY, Chang PY, Sheu JC (2004) Unexpected mortality in pediatric patients with postoperative Hirschsprung’s disease. Pediatr Surg Int 20(7):525–528 Weber TR, Fortuna RS, Silen ML, Dillon PA (1999) Reoperation for Hirschsprung’s disease. J Pediatr Surg 34(1):153-156; discussion 156-7 Yanchar NL, Soucy P (1999) Long-term outcome after Hirschsprung’s disease: patients’ perspectives. J Pediatr Surg 34(7):1152–1160 Ziad F, Katchy KC, Al Ramadan S, Alexander S, Kumar S (2006) Clinicopathological features in 102 cases of Hirschsprung disease. Ann Saudi Med. 26(3):200–204 Anupama B, Zheng S, Xiao X (2007) Ten-year experience in the management of total colonic aganglionosis. J Pediatr Surg. 42(10):1671–1676 Azzis O, Fremond B, Dabadie A, Jouan J, Bracq H, Babut JM (1996) Total colonic form of Hirschsprung disease: treatment and long-term follow-up in 16 cases. Chirurgie 121(3):225–229 Barrena S, Andres AM, Burgos L, Luis AL, Hernandez F, Martinez L, Lopez-Santamaria M, Lassaletta L, Tovar JA (2008) Long-term results of the treatment of total colonic aganglionosis with two different techniques. Eur J Pediatr Surg 18(6):375–379 Bickler SW, Harrison MW, Campbell TJ, Campbell JR (1992) Long-segment Hirschsprung’s disease. Arch Surg 127(9):1047–1050; discussion 1050–1041 Cass DT, Myers N (1987) Total colonic aganglionosis: 30 years’ experience. Pediatr Surg Int 2:68–75 Choe EK, Moon SB, Kim HY, Lee SC, Park KW, Jung SE (2008) Outcomes of surgical management of total colonic aganglionosis. World J Surg 32(1):62–68 Dykes EH, Guiney EJ (1989) Total colonic aganglionosis. J Pediatr Gastroenterol Nutr 8(1):129–132 Emslie J, Krishnamoorthy M, Applebaum H (1997) Long-term follow-up of patients treated with ileoendorectal pull-through and right colon onlay patch for total colonic aganglionosis. J Pediatr Surg 32(11):1542–1544 Escobar MA, Grosfeld JL, West KW, Scherer LR, Rouse TM, Engum SA, Rescorla FJ (2005) Long-term outcomes in total colonic aganglionosis: a 32-year experience. J Pediatr Surg 40(6):955–961 Festen C, Severijnen R, Vanderstaak F, Rieu P (1989) Total colonic aganglionosis - treatment and follow-up. Zeitschrift Fur Kinderchirurgie 44(3):153–155 Galifer RB, Frapier JM, Bosc O, Massip A, Rieu D, Couture A, Veyrac C, Barneon G (1987) Total colonic aganglionosis without ileal involvement - an analysis of 6 cases. Chirur Pediatr 28(3):137–144 Herna´ndez F, Rivas S, Avila LF, Dı´az M, Leal N, Martı´nez L, Murcia J, Olivares P, Marin˜o JM, Lo´pez M, Lassaletta L, Tovar JA (2003) Extensive aganglionosis. Treatment and long term results. Cir Pediatr 16(2):54–57 Hoehner JC, Ein SH, Shandling B, Kim PCW (1998) Long-term morbidity in total colonic aganglionosis. J Pediatr Surg 33(7):961–965 Menezes M, Pini Prato A, Jasonni V, Puri P (2008) Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg 43(9):1696–1699. doi:10.1016/j. jpedsurg.2008.01.072 N-fekete C, Ricour C, Martelli H, Jacob SL, Pellerin D (1986) Total colonic aganglionosis (with or without ileal involvement) a review of 27 cases. J Pediatr Surg 21(3):251–254
123
Pediatr Surg Int 69. Raboei EH (2008) Long-term outcome of total colonic aganglionosis. Eur J Pediatr Surg 18(5):300–302. doi:10.1055/s-20081038495 70. Shen C, Song Z, Zheng S, Xiao X (2009) A comparison of the effectiveness of the Soave and Martin procedures for the treatment of total colonic aganglionosis. J Pediatr Surg 44(12):2355–2358. doi:10.1016/j.jpedsurg.2009.07.056 71. Travassos DV, van der Zee DC (2011) Is complete resection of the aganglionic bowel in extensive total aganglionosis up to the middle ileum always necessary? J Pediatr Surg 46(11):2054–2059
123
72. Tsuji H, Spitz L, Kiely EM, Drake DP, Pierro A (1999) Management and long-term follow-up of infants with total colonic aganglionosis. J Pediatr Surg 34(1):158–161 73. Yeh YT, Tsai HL, Chen CY, Wang JB, Chin TW, Wei CF, Liu CS (2014) Surgical outcomes of total colonic aganglionosis in children: a 26-year experience in a single institute. J Chin Med Assoc 77(10):519–523. doi:10.1016/j.jcma.2014.05.012
ORIGINAL ARTICLE
Familial hirschsprung’s disease: a systematic review Danielle Mc Laughlin1 • Prem Puri1
Accepted: 23 June 2015 Ó Springer-Verlag Berlin Heidelberg 2015
Abstract Introduction Hirschsprung’s disease (HSCR) is a multigenetic disorder with complex inheritance patterns. Population risk is 1 in 5000 but is reported to be increased in families of patients with HSCR. Appropriate counseling of affected families could be assisted by data from a large volume of patients. It was the aim of this study to systematically analyse the patterns of familial HSCR in the published literature. Methods Pubmed Ò database was searched using the terms ‘‘Hirschsprung’s disease’’ and ‘‘familial’’ for studies published between 1980 and 2015 on cohorts of index patients with HSCR reporting on familial recurrence. Studies giving rates of familial HSCR together with the total number of HSCR cases at that centre were included. Results In 4331 index cases of HSCR, an overall rate of 7.6 % familial recurrence was found. In total colonic aganglionosis, 20 % of cases were familial. Recurrence of HSCR within families predominantly occurred in siblings (62 %) and was reported between parent and offspring in 22 % and in other relatives in 16 %. Multiple generations were affected in 15 % of families. Conclusion Familial recurrence of HSCR occurs frequently and should be discussed with families of diagnosed patients. Genetic counseling should be offered in these families and in particular for those patients with long segment and total colonic aganglionosis.
& Prem Puri [email protected] 1
National Children’s Research Centre, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, Ireland
Keywords Hirschsprung’s Disease Familial Total colonic aganglionosis
Introduction Hirschsprung’s disease (HSCR) is a congenital disorder of bowel motility which arises in approximately 1 in 5000 newborns per annum. It is characterised by the absence of ganglion cells in the enteric nervous system extending for a variable distance from the internal anal spincther, due to failure of neural crest derived precursor cell migration or survival during early development [1]. The resulting loss of colonic motility leads to bowel obstruction necessitating corrective surgery to resect the affected segment of colon with pullthrough of normally ganglionated bowel to the anal margin [2]. The functional outcome after surgery for affected children can be influenced by the extent of aganglionosis as well as the presence of co-morbidities [3]. Poor outcomes particularly occur in patients with total colonic aganglionosis (TCA), which accounts for 9 % of all HSCR cases [4]. Disease burden on families can be heightened by the recurrence of HSCR in multiple siblings as well as the inheritance of HSCR in offspring of affected patients. Counseling requires the availability of accurate information for families. HSCR is a multi-genetic condition with complex aetiology [5]. Mutations in RET proto-oncogene and endothelin receptor B (ENDRB) are the most frequent genetic insults [6]. HSCR usually occurs in isolation but can arise in association with Trisomy 21 (up to 10 % of all HSCR) and many other syndromes [7]. Familial recurrence of syndromic forms of HSCR has been reported, for example in multiple endocrine neoplasia (MEN) 2A resulting from RET mutation and in Shah-Waardenburg (WS4) syndrome due to ENDRB mutation [8, 9]. However,
123
Pediatr Surg Int
the majority of HSCR cases are sporadic and are lack definite genetic cause ([80 %). Families of patients with sporadic HSCR are also reported to have an increased risk of HSCR compared to the population risk. In some of these families, genetic screening can identify genetic susceptibility for the disease [10]. Single centre cohort studies report familial recurrence rates for sporadic HSCR ranging from 1 to 10 % [11, 12], illustrating a need for large volume patient data analysis. It was the purpose to this study to review the existing literature in a systematic fashion to identify the rate and patterns of familial recurrence of HSCR.
Methods The Pubmed Ò database was searched using the terms ‘‘Hirschsprung’s’’ and ‘‘familial’’ for studies published between 1980 and 2015. Articles yielded using this search were identified as relevant by abstract review followed by full text analysis. Additional studies of interest were identified by examination of reference lists in relevant articles. Studies including a minimum cohort of 10 index patients with sporadic HSCR were included for the main analysis. Only studies that gave the total number of sporadic HSCR at that centre and reported on familial recurrence were permitted. Studies of multicentre survey data were excluded to avoid duplicated patient cohorts in the analysis. The rate of familial HSCR was calculated as a percentage of the overall number of HSCR cases included in the analysis. Cohorts of patients with TCA were analysed separately. Familial HSCR occurring in association with syndromes or specific genetic mutations was excluded from the main analysis and reported on separately and permitted data from case reports. Patterns of familial HSCR were extracted and categorized as parent–child, sibling or other relative and were reported as a percentage of the total number of families for which recurrence patterns were available. The gender as well as extent of aganglionic segment (long or short) in familial cases were also recorded.
Table 1 Familial recurrence in Hirschsprung’s Disease References
HSCR cases n
Familial cases n
Badner et al. [19]
218
8
Bjornland et al. [20]
48
4
Carter et al. [18]
207
21 3
Cilley et al. [21]
15
De Lagauise et al [22]
55
2
Engum et al. [12]
260
20
Fitze et al. [23]
76
5
Fortuna et al. [24]
82
6
Jakobson-Setton et al. [25]
21
3
Jung et al. [26]
137
4
Klein et al. [27] Koh et al. [28]
26 14
3 2
Lee et al. [29]
44
0
Levitt et al. [11]
67
2
Luis et al. [30]
100
12
Marty et al. [31]
135
23
Moore et al. [32]
118
18
Moore et al. [33]
370
28
More et al. [34]
54
2
Mir et al. [35]
10
1
Murthi et al. [36]
63
2
Neuvonen et al. [37]
146
15
Orr et al. [38]
103
5
Pini Prato et al. [39]
112
9
Reding et al. [40]
59
4
Ruiz-Ferrer et al. [41]
217
27
Russell et al. [42] Ryan et al. [43]
224 179
11 13
Sarioglu et al. [44]
302
6
Shinall et al. [45]
60
2 3
Nah et al. [46]
76
Shono et al. [47]
110
14
Svensson et al. [48]
69
7
Virtanen et al. [49]
91
15
Wang et al. [50]
147
5
Weber et al. [51]
107
8
Yanchar et al. [52]
107
14
Ziad et al. [53]
102
3
Total
4331
330
Results The database search yielded 244 articles. Following abstract review and full text analysis, 38 studies were identified for inclusion in the main analysis (Table 1). In 4331 index cases of HSCR, there were 330 cases in which a family history of HSCR was recorded, giving an overall rate of 7.6 % for familial recurrence. In children with total
123
colonic aganglionosis (n = 525), 20 % of cases were reported to have familial recurrence (Table 2). Recurrence of HSCR within families predominantly occurred in siblings (62 %) and was reported between parent and child in 22 % and in other relatives in 16 %. Multiple generations ([2) were affected in 15 % of families. The gender of familial cases was reported in 202 cases and exhibited a
Pediatr Surg Int Table 2 Familial recurrence in total colonic aganglionois References
TCA cases n
Familial n
Anupuma et al. [54]
25
0
Azzis et al. [55]
16
2
Barrena et al. [56]
41
12
Bickler et al. [57]
21
7
Cass et al. [58]
32
5
Choe et al. [59]
17
4
Dykes et al. [60]
9
1
Emslie et al. [61]
5
1
Escobar et al. [62]
36
10
Festen et al. [63]
11
4
Galifer et al. [64] Hernadez et al. [65]
6 15
1 3
Hoehner et al. [66]
29
4
Marty et al. [31]
12
6
Menezes et al. [67]
58
5
Moore et al. [32]
22
7
Moore et al. [33]
30
11
N-fekete et al. [68]
27
5
Raboei et al. [69]
12
4
Shen et al. [70]
29
4
Travassos et al. [71]
15
2
Tsuji et al. [72]
48
10
Yeh et al. [73]
9
2
Total
525
110
Table 3 Familial recurrence in syndromic HSCR Syndrome
Gene
No. families
RET mutation
RET
42
MEN
RET/GFRA1
19
WS4
ENBRB
14
Goldberg Shprintzen
KIAA1279
7
Neurblastoma
PHOX2B
3
Bardet biedl
–
3
Congenital central hypoventilation
PHOX2B
2
Mowat wilson
ZFH1B
1
Smith lemli optiz
DHCR7
0
ratio of 1.65:1 male:female. Disease segment length was available in 141 cases of familial HSCR only. 39 % of cases were classified as long segment (defined in most studies as proximal to the midpoint of the transverse colon), and 61 % of cases were classified as short segment disease. Recurrence of syndromic HSCR in families was infrequent and is summarised in Table 3. RET mutation or
MEN2A association were the most widely reported [13, 14]. An extended family of Mennonite kindred in the US with a 1 in 500 incidence of HSCR with a susceptibility locus mutation in ENDRB and features of Waardenburg syndrome also featured prominently in the literature [8].
Discussion Our analysis suggests that familial recurrence of HSCR occurs at a higher rate than previously reported by multicentre survey data from the EU (2.6 %) [15] and Japan [16] (2.8–6 %), but our results are similar to a US study which included survey data [17]. We observed high variability in rates of familial recurrence between different centres (Table 3). Nonetheless, this analysis most likely underestimates the rate of familial recurrence of HSCR. In general, the studies included have not been specifically designed to report comprehensive familial data. Recurrence in potential future siblings or other relatives of index patients was not captured. In addition, recurrence in offspring of affected patients is not addressed in any of these studies by longterm follow-up with some exceptions [18]. A relative risk of recurrence of 4 % (200 times the population risk) in siblings has previous been suggested using predictive models [19]; however, further data are required to predict recurrence risk for the future offspring of index patients. These findings reinforce the need for comprehensive follow-up of these and other patients with congenital disorders on a long-term basis to enhance understanding of disease mechanisms for aetiological and clinical purposes. We found that HSCR recurred at a higher rate in families of patients with TCA (in 1 of every 5 cases). These findings are consistent with reports suggesting that TCA represents a distinct entity in terms of aetiology, displaying increased penetrance and dominant inheritance in families of affected patients rather than the multifactorial or recessive patterns of inheritance in other HSCR [6]. Cases of familial recurrence of syndromic HSCR are predominantly limited to RET mutation together with MEN2A or ENDRB mutation together with Shah-Wardenburg syndrome. Other syndromic associations recur within families only very rarely according to the case report literature. Models analysing the gender and the length of the aganglionic segment in index patients have been reported to predict risk of recurrence of HSCR in siblings [19]. We noted that the proportion of female familial cases differed from sporadic HSCR which normally has a male preponderance of 4:1. We additionally noted that a higher number of long segment cases were reported in the familial cases (40 %) than would be expected for sporadic HSCR (15 %).
123
Pediatr Surg Int
In conclusion, familial recurrence of HSCR is frequent and should be discussed with families of index patients. Genetic counseling should be offered in these families and in particular for those patients with long segment and total colonic aganglionosis.
References 1. Heanue TA, Pachnis V (2007) Enteric nervous system development and Hirschsprung’s disease: advances in genetic and stem cell studies. Nat Rev Neurosci 8(6):466–479. doi:10.1038/ nrn2137 2. Langer JC (2012) Laparoscopic and transanal pull-through for Hirschsprung disease. Semin Pediatr Surg 21(4):283–290. doi:10. 1053/j.sempedsurg.2012.07.002 3. Menezes M, Corbally M, Puri P (2006) Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int 22(12):987–990. doi:10.1007/ s00383-006-1783-8 4. Laughlin DM, Friedmacher F, Puri P (2012) Total colonic aganglionosis: a systematic review and meta-analysis of longterm clinical outcome. Pediatr Surg Int 28(8):773–779. doi:10. 1007/s00383-012-3117-3 5. Alves MM, Sribudiani Y, Brouwer RW, Amiel J, Antinolo G, Borrego S, Ceccherini I, Chakravarti A, Fernandez RM, GarciaBarcelo MM, Griseri P, Lyonnet S, Tam PK, van Ijcken WF, Eggen BJ, te Meerman GJ, Hofstra RM (2013) Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model. Dev Biol 382(1):320–329. doi:10. 1016/j.ydbio.2013.05.019 6. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, Pelet A, Arnold S, Miao X, Griseri P, Brooks AS, Antinolo G, de Pontual L, Clement-Ziza M, Munnich A, Kashuk C, West K, Wong KK, Lyonnet S, Chakravarti A, Tam PK, Ceccherini I, Hofstra RM, Fernandez R, Hirschsprung Disease C (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45(1):1–14. doi:10.1136/jmg. 2007.053959 7. Moore SW (2012) Chromosomal and related mendelian syndromes associated with hirschsprung’s disease. Pediatr Surg Int 28(11):1045–1058 8. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell 79(7):1257–1266 9. Verdy M, Weber AM, Roy CC, Morin CL, Cadotte M, Brochu P (1982) Hirschsprung’s disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr 1(4):603–607 10. Garcia-Barcelo M, Sham MH, Lee WS, Lui VC, Chen BL, Wong KK, Wong JS, Tam PK (2004) Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease. Clin Chem 50(1):93–100. doi:10.1373/ clinchem.2003.022061 11. Levitt MA, Hamrick MC, Eradi B, Bischoff A, Hall J, Pena A (2013) Transanal, full-thickness, Swenson-like approach for Hirschsprung disease. J Pediatr Surg 48(11):2289–2295. doi:10. 1016/j.jpedsurg.2013.03.002 12. Engum SA, Petrites M, Rescorla FJ, Grosfeld JL, Morrison AM, Engles D (1993) Familial Hirschsprung’s disease: 20 cases in 12 kindreds. J Pediatr Surg 28(10):1286–1290
123
13. Decker RA, Peacock ML (1998) Occurrence of MEN 2a in familial Hirschsprung’s disease: a new indication for genetic testing of the RET proto-oncogene. J Pediatr Surg 33(2):207–214 14. Coyle D, Friedmacher F, Puri P (2014) The association between Hirschsprung’s disease and multiple endocrine neoplasia type 2a: a systematic review. Pediatr Surg Int 30(8):751–756. doi:10. 1007/s00383-014-3538-2 15. Bourdelat D, Vrsansky P, Pages R, Duhamel B (1997) Duhamel operation 40 years after: a multicentric study. Eur J pediatr surg 7(2):70–76. doi:10.1055/s-2008-1071057 16. Vrsansky P, Bourdelat D, Pages R (1998) Principal modifications of the Duhamel procedure in the treatment of Hirschsprung’s disease. Analysis based on results of an international retrospective study of 2,430 patients. Pediatr Surg Int 13(2–3):125–132 17. Kleinhaus S, Boley SJ, Sheran M, Sieber WK (1979) Hirschsprung’s disease—a survey of the members of the surgical section of the American Academy of Pediatrics. J Pediatr Surg 14(5):588–597 18. Carter CO, Evans K, Hickman V (1981) Children of those treated surgically for Hirschsprung’s disease. J Med Genet 18(2):87–90 19. Badner JA, Sieber WK, Garver KL, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Hum Genet 46(3):568–580 20. Bjornland K, Diseth TH, Emblem R (1998) Long-term functional, manometric, and endosonographic evaluation of patients operated upon with the Duhamel technique. Pediatr Surg Int 13(1):24–28 21. Cilley RE, Statter MB, Hirschl RB, Coran AG (1994) Definitive treatment of Hirschsprung’s disease in the newborn with a onestage procedure. Surgery 115(5):551–556 22. De Lagausie P, Carricaburu E, Ferkadji L, Huaut O, Aigrain Y (2004) Laparoscopic Duhamel procedure: management of 55 cases. Pediatr Endosurg Innov Tech 8(2):119–122. doi:10.1089/ 1092641041360913 23. Fitze G, Appelt H, Ko¨nig IR, Go¨rgens H, Stein U, Walther W, Gossen M, Schreiber M, Ziegler A, Roesner D, Schackert HK (2003) Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Hum Mol Genet 12(24):3207–3214 24. Fortuna RS, Weber TR, Tracy TF Jr, Silen ML, Cradock TV (1996) Critical analysis of the operative treatment of Hirschsprung’s disease. Arch Surg 131(5):520–524 25. Jakobson-Setton A, Weissmann-Brenner A, Achiron R, Kuint J, Gindes L (2015) Retrospective analysis of prenatal ultrasound of children with Hirschsprung disease. Prenat Diagn 35(7):699–702. doi:10.1002/pd.4595 26. Jung PM (1995) Hirschsprung’s disease: one surgeon’s experience in one institution. J Pediatr Surg 30(5):646–651 27. Klein MD, Coran AG, Wesley JR, Drongowski RA (1984) Hirschsprung’s disease in the newborn. J Pediatr Surg 19(4):370–374 28. Koh CE, Yong TL, Fenton EJ (2008) Hirschsprung’s disease: a regional experience. ANZ J Surg 78(11):1023–1027. doi:10. 1111/j.1445-2197.2008.04724.x 29. Lee CC, Lien R, Chiang MC, Yang PH, Chu SM, Fu JH, Lai JY (2012) Clinical impacts of delayed diagnosis of Hirschsprung’s disease in newborn infants. Pediatr Neonatol 53(2):133–137. doi:10.1016/j.pedneo.2012.01.011 30. Luis LA, Encinas JL, Avila LF, Andre´s AM, Burgos L, Ferna´ndez A, Queiza´n A, Olivares P, Lo´pez-Santamarı´a M, Burgos E, Herna´ndez F, Lassaletta L, Tovar JA (2006) Hirschsprung disease: lessons learned from the last 100 cases. Cir Pediatr 19(3):177–181 31. Marty TL, Seo T, Matlak ME, Sullivan JJ, Black RE, Johnson DG (1995) Gastrointestinal function after surgical correction of
Pediatr Surg Int
32.
33.
34.
35.
36.
37.
38. 39.
40.
41.
42. 43.
44.
45.
46.
47.
48.
49.
Hirschsprung’s disease: long-term follow-up in 135 patients. J Pediatr Surg 30(5):655–658 Moore SW, Zaahl M (2010) Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 ‘‘Janus’’ genetic variation. J Pediatr Surg 45(2):393–396. doi:10.1016/j.jpedsurg.2009.10.080 Moore SW, Rode H, Millar AJ, Albertyn R, Cywes S (1991) Familial aspects of Hirschsprung’s disease. Eur J Pediatr Surg 1(2):97–101 More K, Rao S, McMichael J, Minutillo C (2014) Growth and developmental outcomes of infants with Hirschsprung disease presenting in the neonatal period: a retrospective study. J Pediatr 165(1):73–77. doi:10.1016/j.jpeds.2014.02.062 Mir E, Karaca I, Gu¨nsar C, Sencan A, Fesc¸ekoglu O (2001) Primary Duhamel-Martin operations in neonates and infants. Pediatr Int 43(4):405–408 Murthi GV, Raine PA (2003) Preoperative enterocolitis is associated with poorer long-term bowel function after Soave-Boley endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg 38(1):69–72 Neuvonen MI, Kyrklund K, Lindahl HG, Koivusalo AI, Rintala RJ, Pakarinen MP (2015) A population-based, complete followup of 146 consecutive patients after transanal mucosectomy for Hirschsprung disease. J Pediatr Surg. doi:10.1016/j.jpedsurg. 2015.02.006 Orr JD, Scobie WG (1983) Presentation and incidence of Hirschsprung’s disease. Br Med J (Clin Res Ed) 287(6406):1671 Pini Prato A, Gentilino V, Giunta C, Avanzini S, Parodi S, Mattioli G, Martucciello G, Jasonni V (2008) Hirschsprung’s disease: 13 years’ experience in 112 patients from a single institution. Pediatr Surg Int 24(2):175–182 Reding R, de Ville de Goyet J, Gosseye S, Clapuyt P, Sokal E, Buts JP, Gibbs P, Otte JB (1997) Hirschsprung’s disease: a 20-year experience. J Pediatr Surg 32(8):1221–1225 Ruiz-Ferrer M, Torroglosa A, Luzo´n-Toro B, Ferna´ndez RM, Antin˜olo G, Mulligan LM, Borrego S (2011) Novel mutations at RET ligand genes preventing receptor activation are associated to Hirschsprung’s disease. J Mol Med. 89(5):471–480. doi:10.1007/ s00109-010-0714-2 Russell MB, Russell CA, Fenger K, Niebuhr E (1994) Familial occurrence of Hirschsprung’s disease. Clin Genet 45(5):231–235 Ryan ET, Ecker JL, Christakis NA, Folkman J (1992) Hirschsprung’s disease: associated abnormalities and demography. J Pediatr Surg 27(1):76–81 Sarioglu A, Tanyel FC, Bu¨yu¨kpamukc¸u N, Hic¸so¨nmez A (1997) Hirschsprung-associated congenital anomalies. Eur J Pediatr Surg 7(6):331–337 Shinall MC Jr, Koehler E, Shyr Y, Lovvorn HN 3rd (2008) Comparing cost and complications of primary and staged surgical repair of neonatally diagnosed Hirschsprung’s disease. J Pediatr Surg 43(12):2220–2225. doi:10.1016/j.jpedsurg.2008.08.048 Nah SA, de Coppi P, Kiely EM, Curry JI, Drake DP, Cross K, Spitz L, Eaton S, Pierro A (2012) Duhamel pull-through for Hirschsprung disease: a comparison of open and laparoscopic techniques. J Pediatr Surg 47(2):308–312. doi:10.1016/j.jpedsurg. 2011.11.025 Shono K, Hutson JM (1994) The treatment and postoperative complications of Hirschsprung’s disease. Pediatr Surg Int 9(5–6):362–365 Svensson PJ, Molander ML, Eng C, Anvret M, Nordenskjo¨ld A (1998) Low frequency of RET mutations in Hirschsprung disease in Sweden. Clin Genet 54(1):39–44 Virtanen VB, Pukkala E, Kivisaari R, Salo PP, Koivusalo A, Arola J, Miettinen PJ, Rintala RJ, Perola M, Pakarinen MP (2013)
50.
51.
52.
53.
54.
55.
56.
57.
58. 59.
60. 61.
62.
63.
64.
65.
66.
67.
68.
Thyroid cancer and co-occurring RET mutations in Hirschsprung disease. Endocr Relat Cancer 20(4):595–602. doi:10.1530/ERC13-0082 Wang JS, Lee HC, Huang FY, Chang PY, Sheu JC (2004) Unexpected mortality in pediatric patients with postoperative Hirschsprung’s disease. Pediatr Surg Int 20(7):525–528 Weber TR, Fortuna RS, Silen ML, Dillon PA (1999) Reoperation for Hirschsprung’s disease. J Pediatr Surg 34(1):153-156; discussion 156-7 Yanchar NL, Soucy P (1999) Long-term outcome after Hirschsprung’s disease: patients’ perspectives. J Pediatr Surg 34(7):1152–1160 Ziad F, Katchy KC, Al Ramadan S, Alexander S, Kumar S (2006) Clinicopathological features in 102 cases of Hirschsprung disease. Ann Saudi Med. 26(3):200–204 Anupama B, Zheng S, Xiao X (2007) Ten-year experience in the management of total colonic aganglionosis. J Pediatr Surg. 42(10):1671–1676 Azzis O, Fremond B, Dabadie A, Jouan J, Bracq H, Babut JM (1996) Total colonic form of Hirschsprung disease: treatment and long-term follow-up in 16 cases. Chirurgie 121(3):225–229 Barrena S, Andres AM, Burgos L, Luis AL, Hernandez F, Martinez L, Lopez-Santamaria M, Lassaletta L, Tovar JA (2008) Long-term results of the treatment of total colonic aganglionosis with two different techniques. Eur J Pediatr Surg 18(6):375–379 Bickler SW, Harrison MW, Campbell TJ, Campbell JR (1992) Long-segment Hirschsprung’s disease. Arch Surg 127(9):1047–1050; discussion 1050–1041 Cass DT, Myers N (1987) Total colonic aganglionosis: 30 years’ experience. Pediatr Surg Int 2:68–75 Choe EK, Moon SB, Kim HY, Lee SC, Park KW, Jung SE (2008) Outcomes of surgical management of total colonic aganglionosis. World J Surg 32(1):62–68 Dykes EH, Guiney EJ (1989) Total colonic aganglionosis. J Pediatr Gastroenterol Nutr 8(1):129–132 Emslie J, Krishnamoorthy M, Applebaum H (1997) Long-term follow-up of patients treated with ileoendorectal pull-through and right colon onlay patch for total colonic aganglionosis. J Pediatr Surg 32(11):1542–1544 Escobar MA, Grosfeld JL, West KW, Scherer LR, Rouse TM, Engum SA, Rescorla FJ (2005) Long-term outcomes in total colonic aganglionosis: a 32-year experience. J Pediatr Surg 40(6):955–961 Festen C, Severijnen R, Vanderstaak F, Rieu P (1989) Total colonic aganglionosis - treatment and follow-up. Zeitschrift Fur Kinderchirurgie 44(3):153–155 Galifer RB, Frapier JM, Bosc O, Massip A, Rieu D, Couture A, Veyrac C, Barneon G (1987) Total colonic aganglionosis without ileal involvement - an analysis of 6 cases. Chirur Pediatr 28(3):137–144 Herna´ndez F, Rivas S, Avila LF, Dı´az M, Leal N, Martı´nez L, Murcia J, Olivares P, Marin˜o JM, Lo´pez M, Lassaletta L, Tovar JA (2003) Extensive aganglionosis. Treatment and long term results. Cir Pediatr 16(2):54–57 Hoehner JC, Ein SH, Shandling B, Kim PCW (1998) Long-term morbidity in total colonic aganglionosis. J Pediatr Surg 33(7):961–965 Menezes M, Pini Prato A, Jasonni V, Puri P (2008) Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg 43(9):1696–1699. doi:10.1016/j. jpedsurg.2008.01.072 N-fekete C, Ricour C, Martelli H, Jacob SL, Pellerin D (1986) Total colonic aganglionosis (with or without ileal involvement) a review of 27 cases. J Pediatr Surg 21(3):251–254
123
Pediatr Surg Int 69. Raboei EH (2008) Long-term outcome of total colonic aganglionosis. Eur J Pediatr Surg 18(5):300–302. doi:10.1055/s-20081038495 70. Shen C, Song Z, Zheng S, Xiao X (2009) A comparison of the effectiveness of the Soave and Martin procedures for the treatment of total colonic aganglionosis. J Pediatr Surg 44(12):2355–2358. doi:10.1016/j.jpedsurg.2009.07.056 71. Travassos DV, van der Zee DC (2011) Is complete resection of the aganglionic bowel in extensive total aganglionosis up to the middle ileum always necessary? J Pediatr Surg 46(11):2054–2059
123
72. Tsuji H, Spitz L, Kiely EM, Drake DP, Pierro A (1999) Management and long-term follow-up of infants with total colonic aganglionosis. J Pediatr Surg 34(1):158–161 73. Yeh YT, Tsai HL, Chen CY, Wang JB, Chin TW, Wei CF, Liu CS (2014) Surgical outcomes of total colonic aganglionosis in children: a 26-year experience in a single institute. J Chin Med Assoc 77(10):519–523. doi:10.1016/j.jcma.2014.05.012
